Patents by Inventor Seon Joo BAE

Seon Joo BAE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AMPHIREGULIN GENE-SPECIFIC DOUBLE-STRANDED OLIGONUCLEOTIDE AND COMPOSITION FOR PREVENTING AND TREATING FIBROSIS-RELATED DISEASES AND RESPIRATORY DISEASES, COMPRISING SAME
    Publication number: 20230332154
    Abstract: The present invention relates to a double-stranded oligonucleotide which can highly specifically and efficiently inhibit an amphiregulin expression and, preferably, a double-stranded oligonucleotide comprising a sequence in the form of RNA/RNA, DNA/DNA or DNA/RNA hybrid, a double-stranded oligonucleotide structure comprising the double-stranded oligonucleotide, nanoparticles comprising the double-stranded oligonucleotide structure, and a fibrosis or respiratory disease preventive or therapeutic use thereof.
    Type: Application
    Filed: June 7, 2023
    Publication date: October 19, 2023
    Inventors: Tae-Rim KIM, Pyoung Oh YOON, Youngho KO, Seon Joo BAE, Han-Oh PARK, Seung Seob SON, Jun-Hong PARK, Sung-Il YUN
  • AMPHIREGULIN GENE-SPECIFIC DOUBLE-STRANDED OLIGONUCLEOTIDE AND COMPOSITION FOR PREVENTING AND TREATING FIBROSIS-RELATED DISEASES AND RESPIRATORY DISEASES, COMPRISING SAME
    Publication number: 20230203494
    Abstract: The present invention relates to a double-stranded oligonucleotide which can highly specifically and efficiently inhibit an amphiregulin expression and, preferably, a double-stranded oligonucleotide comprising a sequence in the form of RNA/RNA, DNA/DNA or DNA/RNA hybrid, a double-stranded oligonucleotide structure comprising the double-stranded oligonucleotide, nanoparticles comprising the double-stranded oligonucleotide structure, and a fibrosis or respiratory disease preventive or therapeutic use thereof.
    Type: Application
    Filed: December 16, 2022
    Publication date: June 29, 2023
    Inventors: Tae-Rim KIM, Pyoung Oh YOON, Youngho KO, Seon Joo BAE, Han-Oh PARK, Seung Seob SON, Jun-Hong PARK, Sung-II YUN
  • AMPHIREGULIN GENE-SPECIFIC DOUBLE-STRANDED OLIGONUCLEOTIDE AND COMPOSITION FOR PREVENTING AND TREATING FIBROSIS-RELATED DISEASES AND RESPIRATORY DISEASES, COMPRISING SAME
    Publication number: 20210189398
    Abstract: The present invention relates to a double-stranded oligonucleotide which can highly specifically and efficiently inhibit an amphiregulin expression and, preferably, a double-stranded oligonucleotide comprising a sequence in the form of RNA/RNA, DNA/DNA or DNA/RNA hybrid, a double-stranded oligonucleotide structure comprising the double-stranded oligonucleotide, nanoparticles comprising the double-stranded oligonucleotide structure, and a fibrosis or respiratory disease preventive or therapeutic use thereof.
    Type: Application
    Filed: May 22, 2019
    Publication date: June 24, 2021
    Inventors: Tae-Rim KIM, Pyoung Oh YOON, Youngho KO, Seon Joo BAE, Han-Oh PARK, Seung Seob SON, Jun-Hong PARK, Sung-II YUN